Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy
NCT00918827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2128
Last updated 2017-06-02
Summary
RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer who have undergone surgery and chemotherapy may help doctors predict how well patients will respond to treatment.
PURPOSE: This research study is looking at tumor samples from patients with stage III colon cancer who have undergone surgery and chemotherapy.
Conditions
Sponsors & Collaborators
-
Tokyo Medical and Dental University
collaborator OTHER -
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
lead OTHER
Principal Investigators
-
Kenichi Sugihara, MD, PhD · Tokyo Medical and Dental University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-01
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
NCT02510118 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery
NCT03958435 ·Status: UNKNOWN
-
Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection
NCT04457297 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study
NCT05161585 ·Status: UNKNOWN ·Phase: NA
-
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
NCT03532711 ·Status: COMPLETED
-
Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer
NCT03127111 ·Status: NOT_YET_RECRUITING
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2
-
Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety
NCT01465451 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00280761 ·Status: COMPLETED
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
NCT01043172 ·Status: COMPLETED ·Phase: PHASE2
-
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3
-
CRC Post-surgical Assessment and Recurrence Monitoring
NCT03334890 ·Status: UNKNOWN
-
Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
NCT00689364 ·Status: UNKNOWN
-
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer
NCT02316535 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma
NCT00973778 ·Status: UNKNOWN ·Phase: PHASE2
-
MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)
NCT06879873 ·Status: NOT_YET_RECRUITING